PTPRD (Protein Tyrosine Phosphatase Receptor-Type D) is a broadly inactivated phosphatase/tumor suppressor; multi-cancer screening and real-world datasets identify PTPRD mutation as a recurrent event with clinical impact, including in LUAD. Here, PTPRD is linked to neoplasm.